PUBLISHER: The Business Research Company | PRODUCT CODE: 1946979
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946979
Point-of-care devices are medical diagnostic tools designed for use at or near the site of patient care, including clinics, hospitals, or even home settings. Their primary purpose is to provide rapid, on-the-spot test results, enabling timely clinical decisions and immediate treatment. These devices simplify complex laboratory tests, making healthcare more efficient and accessible.
The primary types of point-of-care devices include diagnostic devices, therapeutic devices, monitoring devices, treatment devices, and support devices. Diagnostic devices are medical instruments used to detect, measure, and monitor diseases or health conditions by analyzing patient samples or physiological parameters. They employ technologies such as biochemical assays, microfluidics, immunoassays, nucleic acid testing, and wearable technology, and are applied across fields like cardiology, diabetes management, infectious diseases, oncology, and pediatrics. These devices are distributed through channels including direct sales, distributors, online platforms, retail pharmacies, and healthcare institutions, serving end users across these same channels.
Tariffs have influenced the point of care devices market by increasing costs for imported electronic components, sensors, and microfluidic cartridges used in diagnostic and monitoring devices. Segments such as molecular diagnostics, wearable monitoring devices, and nucleic acid testing are most affected, particularly in Asia-Pacific manufacturing hubs like China and Southeast Asia. These tariffs have led to higher device prices and supply chain restructuring. However, they have also encouraged regional manufacturing, localization of supply chains, and innovation in cost-efficient point of care technologies.
The point of care devices market research report is one of a series of new reports from The Business Research Company that provides point of care devices market statistics, including point of care devices industry global market size, regional shares, competitors with a point of care devices market share, detailed point of care devices market segments, market trends and opportunities, and any further data you may need to thrive in the point of care devices industry. This point of care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The point of care devices market size has grown strongly in recent years. It will grow from $31.46 billion in 2025 to $34.44 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to limited access to centralized laboratories, growing burden of chronic diseases, need for faster clinical decision making, expansion of primary healthcare facilities, rising demand for bedside diagnostics.
The point of care devices market size is expected to see strong growth in the next few years. It will grow to $48.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancements in microfluidics and biosensors, increasing adoption of wearable and remote monitoring devices, growth in home healthcare settings, rising infectious disease surveillance needs, integration of digital health platforms. Major trends in the forecast period include rising adoption of rapid diagnostic testing at care sites, increasing demand for home-based and self-testing devices, miniaturization of diagnostic and monitoring devices, growing focus on decentralized healthcare delivery, expansion of point of care testing in emergency and critical care.
The rising demand for diagnostic imaging is expected to drive the growth of the point-of-care devices market in the coming years. Diagnostic imaging encompasses techniques used to create visual representations of the body's interior for clinical evaluation and medical intervention. This demand is increasing due to the growing prevalence of chronic diseases that require early and accurate diagnosis. Point-of-care devices support diagnostic imaging by offering compact, portable designs suitable for clinics, bedside use, and remote healthcare settings. They improve clinical efficiency by delivering rapid and accurate imaging results, enabling timely decision-making and enhanced patient care. For example, in November 2024, the National Health Service (NHS), a UK-based government agency, reported 47.2 million imaging tests in England for the year ending March 2024, up 4.8% from 45.0 million in the previous year. Consequently, the growing demand for diagnostic imaging is fueling the growth of the point-of-care devices market.
Key players in the point-of-care devices market are developing advanced solutions such as AI-powered handheld ultrasound systems to enhance diagnostic accuracy and portability. These systems are portable imaging devices that leverage artificial intelligence algorithms to assist in capturing and interpreting ultrasound images, enabling faster and more accurate diagnoses. For instance, in October 2023, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched the Compact 5000 Series, an AI-enhanced point-of-care ultrasound system. This portable device delivers high-quality imaging combined with AI-driven automation for measurements and streamlined workflows, enabling rapid and precise diagnostics across diverse healthcare settings. It features intuitive controls, supports multiple transducers, and integrates seamlessly with telemedicine platforms to facilitate collaborative remote patient care.
In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care technology platform from LumiraDx Limited for an undisclosed amount. This acquisition aims to strengthen Roche's presence in decentralized diagnostics by integrating a user-friendly, portable platform capable of performing immunochemistry and clinical chemistry tests, with potential for future molecular diagnostics. LumiraDx Limited is a UK-based diagnostics company specializing in point-of-care devices.
Major companies operating in the point of care devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc., BioMerieux SA, Quidel Corporation, OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, Abaxis Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., PTS Diagnostics LLC, MeMed, Alere Inc., Diagnostics For All Inc.
North America was the largest region in the point of care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the point of care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The point of care devices market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, mobile health diagnostics, chronic disease screening, and real-time clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care devices market also includes sales of portable blood glucose meters, handheld immunoassay analyzers, rapid antigen test kits, mobile hematology analyzers, and compact molecular diagnostic devices. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Point Of Care Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses point of care devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for point of care devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.